Entera Bio (ENTX) Current Assets (2017 - 2026)
Entera Bio's (ENTX) quarterly Current Assets came in at $12.5 million in Q1 2026, down 41.12% YoY from $21.2 million in Q1 2025, and down 18.34% on a QoQ basis from $15.3 million in Q4 2025.
Entera Bio (ENTX) Current Assets (2017 - 2026) Analysis & Trends
Entera Bio (ENTX) has 10 years of Current Assets data on file, last reported at $12.5 million in Q1 2026.
- Quarterly Current Assets fell 41.12% year-over-year to $12.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (down 41.12% YoY) and the FY2025 annual result came in at $15.3 million, up 70.51% from the prior year.
- Current Assets retreated to $12.5 million in Q1 2026, from $15.3 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $21.6 million in Q1 2022 to a low of $7.3 million in Q3 2024.
- A 5-year average of $13.5 million and a median of $12.5 million in 2026 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets slumped 49.27% — and 2025, when it soared 131.7%.
- Tracing ENTX's Current Assets over 5 years: stood at $12.8 million in 2022, then retreated by 12.39% to $11.3 million in 2023, then slipped by 20.3% to $9.0 million in 2024, then jumped by 70.51% to $15.3 million in 2025, then dropped by 18.34% to $12.5 million in 2026.
- The last three Current Assets figures came in at $12.5 million (Q1 2026), $15.3 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | 18.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.90 Mn |
| Mar 31, 2026 | 12.49 Mn |
| Dec 31, 2025 | 15.30 Mn |
| Sep 30, 2025 | 17.01 Mn |
| Jun 30, 2025 | 19.31 Mn |
| Mar 31, 2025 | 21.22 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 9.60 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 8.02 Mn |
| Jun 30, 2023 | 9.81 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 12.85 Mn |
| Sep 30, 2022 | 15.19 Mn |
| Jun 30, 2022 | 18.43 Mn |
| Mar 31, 2022 | 21.64 Mn |
| Dec 31, 2021 | 25.33 Mn |
| Jun 30, 2021 | 27.91 Mn |